These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2967317)

  • 1. Corticosteroids modulate the binding of recombinant interferons alpha and gamma in Namalva cells.
    Diez RA; Mistchenko AS; Falcoff ET
    Immunopharmacol Immunotoxicol; 1987; 9(1):115-28. PubMed ID: 2967317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids enhance the binding of recombinant interferon-gamma to cultured human monocytes.
    Strickland RW; Wahl LM; Finbloom DS
    J Immunol; 1986 Sep; 137(5):1577-80. PubMed ID: 2943796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
    Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Receptor system of interferons].
    Yonehara S
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):44-52. PubMed ID: 6320747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
    Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the human type I interferon receptor by ligand blotting.
    Schwabe M; Princler GL; Faltynek CR
    Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IFN-alpha and IFN-gamma receptors on normal human small resting T lymphocytes and large granular lymphocytes.
    Faltynek CR; Princler GL; Ortaldo JR
    J Immunol; 1986 Jun; 136(11):4134-9. PubMed ID: 2939140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a binding structure for sialic acid-containing glycoconjugates on rat bone marrow-derived macrophages and its modulation by IFN, TNF-alpha, and dexamethasone.
    Gessl A; Boltz-Nitulescu G; Wiltschke C; Holzinger C; Nemet H; Pernerstorfer T; Förster O
    J Immunol; 1989 Jun; 142(12):4372-7. PubMed ID: 2470823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells.
    Dooley JS; Vergalla J; Hoofnagle JH; Zoon KC; Munson PJ; Jones EA
    J Lab Clin Med; 1989 May; 113(5):623-31. PubMed ID: 2523945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration and partial characterization of the interferon-gamma receptor on human B lymphocytes.
    Nakagawa T; Nakagawa N; Delsing GA; Volkman D; Kehrl JH
    J Cell Biochem; 1989 Aug; 40(4):417-30. PubMed ID: 2528554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
    Dunne SL; Bajzer Z; Vuk-Pavlović S
    Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
    Taniguchi S; Dai CH; Krantz SB
    Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data.
    Merlin G; Falcoff E; Aguet M
    J Gen Virol; 1985 May; 66 ( Pt 5)():1149-52. PubMed ID: 3158718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line.
    Chakravarthy A; Chen LC; Mehta D; Hamburger AW
    Anticancer Res; 1991; 11(1):347-51. PubMed ID: 1902074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle.
    Chang AY; Keng PC
    Cancer Res; 1987 Aug; 47(16):4338-41. PubMed ID: 2440565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor and transforming growth factor-alpha decrease gamma interferon receptors and induction of intercellular adhesion molecule (ICAM-1) on cultured keratinocytes.
    Mitra RS; Nickoloff BJ
    J Cell Physiol; 1992 Feb; 150(2):264-8. PubMed ID: 1346399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon.
    Pfeffer LM; Donner DB
    Cancer Res; 1990 May; 50(9):2654-7. PubMed ID: 2139358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy.
    Lau AS; Hannigan GE; Freedman MH; Williams BR
    J Clin Invest; 1986 May; 77(5):1632-8. PubMed ID: 3009549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.